Clinical trial
Long-term Treatment With Trazodone Once-a-Day (TzOAD) in Patients With MDD: an Observational, Prospective Study
NCT04295941 is registered in ClinicalTrials.gov with Aziende Chimiche Riunite Angelini Francesco S.p.A as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Treatment With Trazodone Once-a-Day (TzOAD) in Patients With MDD: an Observational, Prospective Study
- Lead sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 23, 2020
- Completion date
- November 16, 2021
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.